Ainos, Inc. (NASDAQ:AIMD) Short Interest Up 69.5% in March

Ainos, Inc. (NASDAQ:AIMD) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 402,500 shares, an increase of 69.5% from the February 28th total of 237,400 shares. Approximately 12.0% of the company’s shares are sold short. Based on an average daily trading volume, of 637,300 shares, the days-to-cover ratio is currently 0.6 days.

Ainos Trading Down 1.9 %

NASDAQ AIMD opened at $0.51 on Friday. The business’s 50-day moving average price is $0.60 and its two-hundred day moving average price is $0.53. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $7.87 million, a PE ratio of -0.31 and a beta of 1.51. Ainos has a 12 month low of $0.40 and a 12 month high of $1.46.

Ainos (NASDAQ:AIMD) last issued its quarterly earnings results on Friday, March 7th. The company reported ($0.26) EPS for the quarter.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.